Schröder R, Park J H, O'Brien P Q. "一种吉非替尼杂质74的合成方法" [P]. US Patent, US 10005481 B2, 2023-02-17.
Björnsson E, Rossi M, Schröder R. "Method for the Synthesis of Gefitinib Impurity 74" [P]. European Patent, EP 3530936 A1, 2017-05-13.
发明人周伟,何建平,韩伟. "A Process for Preparing High-Purity Gefitinib Impurity 74" [P]. 中国发明专利, 专利号 CN 116628271 B, 授权公告日 2018-10-17.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质74 in Pharmaceutical Formulations". Sci. Total Environ., 2013, 2082, (6), 8650-8669.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质74 as an Impurity". J. Agric. Food Chem., 2020, 1880, (5), 9097-9105.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 74 Using HRMS and NMR". Biomed. Chromatogr., 2014, 1820, (5), 391-404.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 吉非替尼杂质74 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2025, 378, 8402-8421.